Vincent J Willey
Overview
Explore the profile of Vincent J Willey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
537
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Richard E, Desai N, Willey V, Gay A, Scott C, Folkerts K, et al.
Pragmat Obs Res
. 2025 Mar;
16:27-37.
PMID: 40034401
Purpose: This study aimed to describe the characteristics, treatment patterns, adverse events (AEs), and clinical outcomes of patients starting steroidal mineralocorticoid receptor antagonists (sMRAs) in real-world settings. Methods: The RELICS...
2.
Hoffman S, Kalloo G, Lanes S, Jamal-Allial A, Sponholtz T, Brooks C, et al.
Pharmacoepidemiol Drug Saf
. 2025 Feb;
34(2):e70109.
PMID: 39953813
Purpose: Many post-authorization safety studies focus on congenital malformations and rely on diagnosis codes found in US data sources. However, no authoritative standards exist for identifying and classifying malformations in...
3.
Barron J, Willey V, Doherty B, Tunceli O, Waltz C, Grabner M, et al.
Pharmacoepidemiol Drug Saf
. 2025 Feb;
34(2):e70110.
PMID: 39909722
Background And Methods: The Healthcare Integrated Research Database (HIRD) is a large, comprehensive real-world data (RWD) source for health-related research. Demographic and healthcare-related characteristics of individuals are sourced from routinely...
4.
Nguyen C, Crowe C, Kuti E, Donato B, Djaraher R, Seman L, et al.
J Health Econ Outcomes Res
. 2024 May;
11(1):112-121.
PMID: 38779335
The economic burden associated with type 2 diabetes mellitus (T2DM) and concurrent cardiovascular disease (CVD) among patients with COVID-19 is unclear. We compared healthcare resource utilization (HCRU) and costs in...
5.
Silberman J, Wicks P, Patel S, Sarlati S, Park S, Korolev I, et al.
NPJ Digit Med
. 2023 May;
6(1):101.
PMID: 37258851
Dozens of frameworks have been proposed to assess evidence for digital health interventions (DHIs), but existing frameworks may not facilitate DHI evidence reviews that meet the needs of stakeholder organizations...
6.
Nguyen C, Bamber L, Willey V, Evers T, Power T, Stephenson J
Patient Prefer Adherence
. 2023 May;
17:1181-1196.
PMID: 37163154
Background: Patient-reported health related quality of life (HRQOL) is not routinely assessed in clinical practice. Little is known about health status outcomes reported by patients with heart failure with preserved...
7.
Buse J, Nordahl Christensen H, Harty B, Mitchell J, Soule B, Zacherle E, et al.
BMJ Open Diabetes Res Care
. 2023 May;
11(3).
PMID: 37137527
Introduction: Once-weekly subcutaneous semaglutide, a glucagon-like peptide-1 analog, is approved in the USA as an adjunct to diet and exercise for adults with inadequately controlled type 2 diabetes (T2D) to...
8.
Nguyen C, Crowe C, Kuti E, Narsipur N, Donato B, Pepe R, et al.
Diabetes Obes Metab
. 2023 Mar;
25(9):2464-2472.
PMID: 36999236
Aim: To compare adverse outcomes among COVID-19 patients with pre-existing type 2 diabetes (T2D) only, T2D and cardiovascular disease (CVD), or neither. Methods: This retrospective cohort study used administrative claims,...
9.
Chung H, Crowe C, Kong S, Singh R, Farej R, Elliott J, et al.
J Manag Care Spec Pharm
. 2022 Dec;
29(1):80-89.
PMID: 36580126
Chronic kidney disease (CKD) is a major public health concern that affects 37 million adults in the United States. It is well known that CKD presents a large economic burden,...
10.
Willey V, Crowley M
Diabetes Care
. 2022 Dec;
45(12):2808-2810.
PMID: 36455130
No abstract available.